Results 181 to 190 of about 56,198 (306)
Single-cell RNA sequencing reveals key signaling pathways and biological functions in giant cell tumors of bone. [PDF]
Lin Z, Chen Z.
europepmc +1 more source
The “Reducing Inflammation for Greater Health Trial (RIGHT)” Study—Concept, Rationale, and Design
ABSTRACT The Reducing Inflammation for Greater Health Trial's (RIGHT) study is a single‐center, randomized, double‐blind, placebo‐controlled trial designed to test whether clazkizumab, an interleukin‐6 (IL‐6) inhibitor, can improve or slow decline in physical, cognitive, and vascular function in older adults, when compared to a placebo.
Sebastian E. Sattui +11 more
wiley +1 more source
Do Unresectable Giant Cell Tumors of Bone Treated With Denosumab Progress After Discontinuation of Treatment? [PDF]
DENO Research Group +20 more
europepmc +1 more source
Molecular Alterations in Osteosarcomas of the Oral and Maxillofacial Region: A Scoping Review
ABSTRACT Background Given the rarity and aggressive nature of osteosarcomas (OS) in the oral and maxillofacial region, understanding their molecular alterations is essential to improve diagnosis, prognosis, and guide targeted therapies. This study aimed to map molecular alterations associated with oral and maxillofacial OS, providing an overview of the
Iara Vieira Ferreira +6 more
wiley +1 more source
Rare features of giant cell tumors of the bone: A case report. [PDF]
Wang C +5 more
europepmc +1 more source
Gossypiboma‐associated sarcomas in five cases
Objectives To report clinical presentation, treatment and outcome of dogs and cats diagnosed with gossypiboma‐associated sarcoma. Materials and Methods Referral centres within the United Kingdom, Europe, North America and Australia were contacted to search medical records for dogs and cats with documented gossypiboma‐associated sarcoma and included if ...
G. Thomas +8 more
wiley +1 more source
Recurrence and Risk Factors of Giant Cell Tumors in Hand Bones: A Systematic Review. [PDF]
Berger O +4 more
europepmc +1 more source

